The invention relates to the use of 2-substituted estra-1,3,5(10)-triene-3-yl sulfamates of general formula I, in addition to their pharmaceutically acceptable salts for producing a medicament. Said compounds have an anti-tumour action.
该发明涉及使用一般式I中的2-取代的estra-1,3,5(10)-
三烯-3-基
磺酸盐,以及其药学上可接受的盐来制备药物。这些化合物具有抗肿瘤作用。